Does Caffeine Interact with Dipyridamole?
CDI records a major classification for Caffeine and Dipyridamole. The stored summary is: Caffeine may abolish the coronary vasodilation induced by intravenous dipyridamole, potentially leading to false negative thallium imaging results. The mechanism involves antagonism of coronary vasodilation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Dipyridamole Class
- Platelet Aggregation Inhibitor
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Antagonism of coronary vasodilation
What To Tell Your Doctor or Pharmacist
If you are taking Caffeine and your doctor is considering prescribing Dipyridamole (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider